Myers Ronald, Lavu Harish, Keith Scott W, Kelly Heidi, O'Rourke Nadine, Cocroft James, Quinn Anna, Potluri Vishnu, Yeo Charles J
J Registry Manag. 2014 Winter;41(4):196-200.
Cancer registries play a vital role in research, as they provide important data that can be used to assess disease etiology and risk. Specialty registries can help to address the need for information on defined cancer types. However, achieving high rates of participation in such registries is problematic.We studied the impact of decision support on patient participation in a hospital-based pancreas cancer registry, the Jefferson Pancreas Tumor Registry (JPTR). In this study, we assembled a nonrandomized cohort of 40 patients, of whom 20 were exposed to the intervention and 20 were exposed to routine recruiting methods. Patients in the control group were invited to join the JPTR; while those in the intervention group were also invited to join the JPTR, and received decision support related to participation. Registry participation was assessed at 90 days. At baseline, patient gender, race, and stage of pancreatic cancer did not vary significantly between study groups. Overall, participation in the intervention group was significantly higher (P = 0.01) than in the control group (55% and 10%, respectively). In the intervention group, altruism was the major factor motivating patient participation, while patient concerns related to treatment recovery, registration time and complexity, and the confidentiality of registry data discouraged participation.
癌症登记处在研究中发挥着至关重要的作用,因为它们提供了可用于评估疾病病因和风险的重要数据。专科登记处有助于满足对特定癌症类型信息的需求。然而,要在这些登记处实现高参与率存在问题。我们研究了决策支持对患者参与基于医院的胰腺癌登记处(杰斐逊胰腺肿瘤登记处,JPTR)的影响。在本研究中,我们组建了一个40名患者的非随机队列,其中20名患者接受干预,20名患者接受常规招募方法。对照组患者被邀请加入JPTR;而干预组患者也被邀请加入JPTR,并获得与参与相关的决策支持。在90天时评估登记处参与情况。在基线时,研究组之间患者的性别、种族和胰腺癌分期没有显著差异。总体而言,干预组的参与率显著高于对照组(分别为55%和10%,P = 0.01)。在干预组中,利他主义是促使患者参与的主要因素,而患者对治疗恢复、登记时间和复杂性以及登记处数据保密性的担忧阻碍了参与。